Goldman Sachs Group Inc Calyxt, Inc. Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 14, 2024	BUY	$0.13 - $0.2 $1,828 - $2,813	14,065 New	14,065 $2,000
Q4 2022 Feb 13, 2023	BUY	$0.13 - $0.2 $1,828 - $2,813	14,065 New	14,065 $2,000
Q4 2021 Feb 14, 2022	SELL	$2.06 - $4.05 $24,040 - $47,263	-11,670 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.18 - $5.08 $37,110 - $59,283	11,670 New	11,670 $39,000

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.